Reliability and validity of the Comprehensive Assessment of the at Risk Mental State, Italian version (CAARMS-I)

Current Pharmaceutical Design

Volumn 18, Issue 4, 2012, Pages 386-391

  Fusar Poli, P ^a   Hobson, R ^b   Raduelli, M ^c   Balottin, U ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c Psychiatric Unit   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

ARMS; CAARMS; Prodromal; Psychosis; Psychosis risk; Schizophrenia; Ultra high risk

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COMPREHENSIVE ASSESSMENT OF THE AT RISK MENTAL STATE; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CONTROLLED STUDY; HUMAN; INTERNAL COHERENCE; INTERRATER RELIABILITY; MENTAL HEALTH; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOSIS; RELIABILITY; SCORING SYSTEM; SEMI STRUCTURED INTERVIEW; VALIDITY;

ADOLESCENT; ADULT; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MENTAL DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84856528021     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799316118     Document Type: Article

References (57)

1. Howes OD, Lim SJ, Fusar-Poli P. Mind the translation gap:problems in the implementation of early intervention services. Psychol Med 2010; 40: 171-2.
2. Fusar-Poli P, Valmaggia L, McGuire P. Can antidepressants prevent psychosis? Lancet 2007; 370: 1746-8.
3. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin 1996; 22: 283-303.
4. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research 2004; 67: 131-42.
5. Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E, Lesser ML, Tai JY, Shah MR, Foley CA, Kane JM, Correll CU. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. Journal of Clinical Psychiatry 2007; 68: 546-57.
6. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, Phillips LJ, Bechdolf A, Buckby J, McGorry PD. Validation of prodromal criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res 2008; 105: 10-7.
7. Schultze-Lutter F. Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull 2009; 35: 5-8.
8. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158-64.
9. Fusar-Poli P, Byrne M, Valmaggia L, Day F, Tabraham P, Johns L, McGuire P. Social dysfunction preducts two years clinical outcomes in people at ultrahigh risk for psychosis. Journal of Psychiatric Research 2009; 44: 294-301.
10. Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R, Seal M, Surguladze SA, O'Carrol C, Atakan Z, Zuardi AW, McGuire PK. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 2009; 66: 95-105.
11. Pukrop R, Klosterkotter J. Neurocognitive indicators of clinical high-risk states for psychosis: a critical review of the evidence. Neurotox Res 2010; 18: 272-86.
12. Fusar-Poli P, Borgwardt S, Crescini A, D'Este G, Kempton M, Lawrie S, Guire PM, Sacchetti E. Neuroanatomy of Vulnerability to Psychosis: A Voxel-Based Meta-Analysis. Neurosci Biobehav Rev 2011; 35(5):1175-85.
13. Borgwardt SJ, McGuire P, Fusar-Poli P, Radue EW, Riecher-Rossler A. Anterior cingulate pathology in the prodromal stage of schizophrenia. Neuroimage 2008; 39: 553-4.
14. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz R, Drewe J, Radue E, McGuire P, Riecher-Rössler A, Borgwardt S. Neuroimaging predictors of transition to psychosis - A systematic review and meta-analysis. Neuroscience and Biobehavioural Reviews 2010; 34: 1207-1222.
15. Fusar-Poli P, Perez J, Broome M, Borgwardt S, Placentino A, Caverzasi E, Cortesi M, Veggiotti P, Politi P, Barale F, McGuire P. Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 2007; 31: 465-84.
16. Broome MR, Matthiasson P, Fusar-Poli P, Woolley J, Johns L, Tabraham P, Bramon E, Valmaggia L, Williams S, Brammer M, Chitnis X, McGuire P. Neural correlates of executive function and working memory in the 'at-risk mental state'. Br J Psychiatry 2009; 194: 25-33.
17. Crossley NA, Mechelli A, Fusar-Poli P, Broome MR, Matthiasson P, Johns LC, Bramon E, Valmaggia L, Williams SC, McGuire PK. Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Hum Brain Mapp 2009; 30: 4129-37.
18. Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, Grasby PM, McGuire PK. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry 2010; 67: 683-91.
19. Fusar-Poli P, Stone J, Broome M, Valli I, Mechelli A, McLean M, Lythgoe D, O'Gorman R, Barker G, McGuire P. Thalamic glutamate levels predicts cortical response during executive functioning in subjects at high risk for psychosis. Arch Gen Psychiatry 2011; 68(9): 881-90.
20. Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, Montgomery AJ, Grasby PM, McGuire P. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry 2011; 16(1):67-75.
21. Fusar-Poli P, Allen P, McGuire P. Neuroimaging studies of the early stages of psychosis: a critical review. Eur Psychiatry 2008; 23: 237-44.
22. McGuire P, Howes OD, Stone J, Fusar-Poli P. Functional neuroimaging in schizophrenia: diagnosis and drug discovery. Trends Pharmacol Sci 2008; 29: 91-8.
23. Fusar-Poli P, Broome MR. Conceptual issues in psychiatric neuroimaging. Curr Opin Psychiatry 2006; 19: 608-12.
24. Fusar-Poli P, Borgwardt S, Valmaggia L. Heterogeneity in the assessment of the at-risk mental state for psychosis. Psychiatr Serv 2008; 59: 813.
25. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton M, Barale F, Caverzasi E, McGuire P. Predicting psychosis: a metaanalysis of evidence. Arch Gen Psychiatry 2012: in press.
26. Ruhrmann S, Schultze-Lutter F, Bechdolf A, Klosterkotter J. Intervention in at-risk states for developing psychosis. Eur Arch Psychiatry Clin Neurosci 2010; 260 Suppl 2: S90-S94.
27. Fusar-Poli P, Broome MR, Matthiasson P, Williams SC, Brammer M, McGuire PK. Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study. Eur Neuropsychopharmacol 2007; 17: 492-500.
28. Corcoran CM, First MB, Cornblatt B. The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis. Schizophr Res 2010; 120: 16-22.
29. Ruhrmann S, Schultze-Lutter F, Klosterkotter J. Probably at-risk, but certainly ill--advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res 2010; 120: 23-37.
30. Nelson B, Yung AR. Should a risk syndrome for first episode psychosis be included in the DSM-V? Curr Opin Psychiatry 2011; 24(2):128-33.
31. Shrivastava A, McGorry PD, Tsuang M, Woods SW, Cornblatt BA, Corcoran C, Carpenter W. Attenuated psychotic symptoms syndrome as a risk syndrome of psychosis, diagnosis in DSM-V: The debate. Indian J Psychiatry 2011; 53: 57-65.
32. Woods SW, Walsh BC, Saksa JR, McGlashan TH. The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res 2010; 123: 199-207.
33. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005; 39: 964-71.
34. Miyakoshi T, Matsumoto K, Ito F, Ohmuro N, Matsuoka H. Application of the Comprehensive Assessment of At-Risk Mental States (CAARMS) to the Japanese population: reliability and validity of the Japanese version of the CAARMS. Early Interv Psychiatry 2009; 3: 123-30.
35. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, Patton GC, Jackson HJ. Prediction of psychosis - A step towards indicated prevention of schizophrenia. British Journal of Psychiatry 1998; 172: 14-20.
36. Coren S. Measurement of handedness via self-report: the relationship between brief and extended inventories. Percept Mot Skills 1993; 76: 1035-42.
37. Kay SR. Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison. Psychiatr Q 1990; 61: 163-78.
38. Barkus EJ, Stirling J, Hopkins RS, Lewis S. Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 2006; 39: 175-8.
39. Nelson HE, Willison JR. National Adult Reading Test (NART): Test Manual 2nd ed, NFER-Nelson Windsor, England 1991.
40. Hall R. Global assessment of functioning. A modified scale. Psychosomatics 1995; 36: 267-275.
41. Fusar-Poli P, Allen P, Lee F, Surguladze S, Tunstall N, Fu CH, Brammer MJ, Cleare AJ, McGuire PK. Modulation of neural response to happy and sad faces by acute tryptophan depletion. Psychopharmacology 2007; 193: 31-44.
42. McGraw K, Wong S. Forming Inferences About Some Intraclass Correlation Coefficients. Psychol Med 1996; 1: 30-46.
43. Nunnally J, Bernstein I. Psychometric theory, McGraw-Hill: New York 1994.
44. Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, Keefe RS, Heinssen R, Cornblatt BA. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry 2010; 67: 578-88.
45. Francey SM, Jackson HJ, Phillips LJ, Wood SJ, Yung AR, McGorry PD. Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophrenia Research 2005; 79: 127-36.
46. Hafner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkotter J, Wagner M, Maier W, Bottlender R, Moller HJ, Gaebel W, Wolwer W. Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 2004; 254: 117-28.
47. Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, von Reventlow HG, French P, Stevens H, Schultze-Lutter F, Klosterkotter J, Ruhrmann S. Disability in people clinically at high risk of psychosis. Br J Psychiatry 2010; 197: 278-84.
48. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophrenia Bulletin 2009; 35: 894-908.
49. Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high risk for psychosis. Schizophr Res 2008; 99: 119-24.
50. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res 2004; 68: 37-48.
51. Fusar-Poli P, Meneghelli A, Valmaggia L, Allen P, Galvan F, McGuire P, Cocchi A. Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis. Br J Psychiatry 2009; 194: 181-2.
52. Yung AR, Stanford C, Cosgrave E, Killackey E, Phillips L, Nelson B, McGorry PD. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophrenia Research 2006; 84: 57-66.
53. Schimmelmann BG, Michel C, Schaffner N, Schultze-Lutter F. What percentage of people in the general population satisfies the current clinical at-risk criteria of psychosis? Schizophr Res 2011; 125: 99-100.
54. Green CE, McGuire PK, Ashworth M, Valmaggia LR. Outreach and Support in South London (OASIS). Outcomes of non-attenders to a service for people at high risk of psychosis: the case for a more assertive approach to assessment. Psychol Med 2011; 41: 243-50.
55. French P, Shryane N, Bentall RP, Lewis SW, Morrison AP. Effects of cognitive therapy on the longitudinal development of psychotic experiences in people at high risk of developing psychosis. Br J Psychiatry Suppl 2007; 51: s82-7.
56. Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, Lewis SW. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in peopleat ultrahigh risk. Schizophr Bull 2007; 33: 682-7.
57. Yung AR, Phillips JL, Nelson B, Francey S, Panyuen H, Simmons M, Rossi M, Kelly D, Baker K, Amminger GP, Berger G, Thompson A, Thampi A, McGorry PD. Randomized controlled trial of interventions for young people at ultra high risk for psychosis:_ 6-months analysis. J Clin Psychiatry 2011; 72(4): 430-40.